Navigation Links
Elekta Negotiates To Acquire CMS
Date:1/8/2008

oftware systems for proton therapy facilities and strengthen the collaboration between Elekta and its current partners in this area.

"The products and market position of CMS are highly complementary to Elekta's corporate structure, technology portfolio, and R&D roadmap. Both Elekta's and CMS customers will benefit from our combined strength in product development and support. With CMS in the Elekta Group, we will also gain relationships with a large number of customers who do not use Elekta's products today," explains Tomas Puusepp, President & CEO of Elekta. "Elekta and CMS share a common belief in open systems, and a vision that radiation treatment planning is a critical piece of the technology required for emerging radiation therapy treatment capabilities such as VMAT and adaptive therapy. Together, CMS and Elekta can offer and further develop solutions that optimize clinical workflow while also providing well-defined interfaces that allow clinicians to choose systems that best fit their specific needs."

New trends in radiation therapy planning

"The radiation therapy discipline continues to advance and radiation therapy planning, along with treatment delivery and management technology, enables clinicians to develop and deliver regimens that hopefully will result in improved treatment outcomes," explains James P. Hoey, EVP Product Creation at Elekta and CEO of IMPAC Medical Systems, an Elekta company. "Elekta recognizes that treatment planning is rapidly evolving from an event that typically occurred in an isolated area one or two times during the therapy process to becoming a more iterative process that evolves throughout the course of therapy with various steps taking place in different areas of the department. Our aggressive development of MOSAIQ(TM) RTP as the world's first distributed toolset for advanced radiation therapy is targeted to meet this growing demand. CMS, with several leading solutions already in clinical use, and a strong pi
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
2. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
3. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
4. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
5. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
9. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
10. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
11. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... The Pistoia Alliance, a global, ... life science R&D, has attracted a number of new members from across the ... company joining as a Core member, and DNAnexus and Tessella as Participating members. ...
(Date:7/6/2015)... , July 6, 2015  Emdeon ... into a definitive agreement to acquire Altegra ... intervention platforms that combine data aggregation and ... capabilities to achieve actionable insights and improved ... combine Altegra Health,s risk adjustment and quality ...
(Date:7/6/2015)... 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: ... Novella Clinical (Novella), to conduct the phase ... diagnosed glioblastoma. Novella is a full-service, global clinical research ... mid-sized oncology companies. The ICT-107 phase 3 trial will ... Europe and Canada ...
(Date:7/3/2015)... ... July 03, 2015 , ... The global failure analysis market is expected to ... The bioscience market is expected to grow at the highest CAGR of 8.46%; its ... in the research labs and academic institutions for root cause analysis of failure. The ...
Breaking Biology Technology:Pistoia Alliance Continues to Attract New Members 2Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... March 28, 2012  Regado Biosciences, Inc., a privately held ... control agents, announced that David J. Mazzo, PhD, President ... 11th Annual Healthcare Conference at 10 a.m. EDT on ... in New York City. The presentation will ...
... little dry ice and a simple industrial process cheaply ... Case Western Reserve University report. Graphene, which ... in pencils, has been hailed as the most important ... than copper, heat better than any material known, are ...
... March 26, 2012 Aviir, a biotechnology company dedicated ... tests and Guard A Heart, a non-profit foundation committed ... Storyland, a Red Carpet Charity Extravaganza in Hollywood on ... whimsical Dr. Seuss theme, as homage to the children ...
Cached Biology Technology:Regado Biosciences, Inc. to Present at Needham & Company's 11th Annual Healthcare Conference in New York, NY 2Regado Biosciences, Inc. to Present at Needham & Company's 11th Annual Healthcare Conference in New York, NY 3Simple, cheap way to mass-produce graphene nanosheets 2Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood 2Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood 3
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
(Date:6/24/2015)... 24, 2015 This report provides market analysis ... six years. It contains an analysis of the drivers, ... their impact from the short, medium, and long term ... industry, market, and technology trends that currently, prevail in ... concerned authorities to efficiently manage the increasing marine traffic ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... new species of bird in Gabon, Africa, that was, ... were published in the international science journal Zootaxa today, ... (Stiphrornis pyrrholaemus) was named by the scientists for its ... inches in length and average 18 grams in weight. ...
... A new systematic analysis of the relationship between ... of trends in cancer gene expression. The research, ... Genome Biology, describes how cancers can be divided ... Isaac S Kohane from Children,s Hospital Boston ...
... 14 L-1 Identity,Solutions, Inc. (NYSE: ID ), ... that it closed its tender offer for all of ... and completed its,acquisition of Digimarc,s ID systems business., ... expired at,5:00 p.m. (ET) on August 13, 2008. Through ...
Cached Biology News:Smithsonian scientists discover new bird species 2Smithsonian scientists discover new bird species 3Cancer signatures uncovered 2L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation 2L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation 3
... Methylated Protein Molecular Weight Markers, 37 kBq, ... molecular weight determination of the sample on ... monitoring of band migration in the gel ... the [14C] version without Rainbow-labeling is 0.37-3.7 ...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
... Blunt TOPO PCR Cloning ... designed for cloning and ... PCR products. The pCR4Blunt-TOPO ... Cloning and greater than ...
... 1 EA. Ultrospec 6300 pro ... of the Pharmacopoeia in terms of instrument ... of being able to be used for ... and excellent scanning capability., *Press to read ...
Biology Products: